Novo Nordisk A/S
CSE:NOVO B
Novo Nordisk A/S
CSE:NOVO B
Price:
850.6 DKK
-2.58%
Market Closed
Updated:
May 6, 2024
Novo Nordisk A/S
Depreciation & Amortization
|
Novo Nordisk A/S
Depreciation & Amortization Peer Comparison
Comparables:
HLUN A
ALK B
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Novo Nordisk A/S
CSE:NOVO B
|
Depreciation & Amortization
-kr2.3B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
|
H Lundbeck A/S
CSE:HLUN A
|
Depreciation & Amortization
-kr117m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
ALK-Abello A/S
CSE:ALK B
|
Depreciation & Amortization
-kr82m
|
CAGR 3-Years
4%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
See Also
What is Novo Nordisk A/S's Depreciation & Amortization?
Depreciation & Amortization
-2.3B
DKK
-2.3B
DKK
Based on the financial report for Dec 31, 2023, Novo Nordisk A/S's Depreciation & Amortization amounts to -2.3B DKK.
What is Novo Nordisk A/S's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
-13%
-13%
Over the last year, the Depreciation & Amortization growth was 6%. The average annual Depreciation & Amortization growth rates for Novo Nordisk A/S have been -2% over the past three years , -13% over the past five years .
You don't have any saved screeners yet
